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Vaccine Message Framing and Parents’ Intent to
Immunize Their Infants for MMR
WHAT’S KNOWN ON THIS SUBJECT: Messages emphasizing
societal beneﬁts of vaccines have been linked to increased
vaccination intentions in adults. It is unclear if this pattern holds
for parents deciding whether to vaccinate their children.
WHAT THIS STUDY ADDS: Findings suggest that health care
providers should emphasize the direct beneﬁts of MMR
vaccination to the child. Mentioning societal beneﬁts seems to
neither add value to, nor interfere with, information highlighting
beneﬁts directly to the child.
abstract
BACKGROUND AND OBJECTIVE: Emphasizing societal beneﬁts of vac-
cines has been linked to increased vaccination intentions in adults.
It is unclear if this pattern holds for parents deciding whether to vac-
cinate their children. The objective was to determine whether empha-
sizing the beneﬁts of measles-mumps-rubella (MMR) vaccination directly
to the vaccine recipient or to society differentially impacts parents’
vaccine intentions for their infants.
METHODS: In a national online survey, parents (N = 802) of infants
,12 months old were randomly assigned to receive 1 of 4 MMR
vaccine messages: (1) the Centers for Disease Control and Prevention
Vaccine Information Statement (VIS), (2) VIS and information empha-
sizing the MMR vaccine’s beneﬁts to the child, (3) VIS and information
emphasizing societal beneﬁts, or (4) VIS and information emphasizing
beneﬁts both to the child and society. Parents reported their likeli-
hood of vaccinating their infants for MMR on a response scale of
0 (extremely unlikely) to 100 (extremely likely).
RESULTS: Compared with the VIS-only group (mean intention = 86.3),
parents reported increased vaccine intentions for their infants when
receiving additional information emphasizing the MMR vaccine’s
beneﬁts either directly to the child (mean intention = 91.6, P = .01) or
to both the child and society (mean intention = 90.8, P = .03). Emphasizing
the MMR vaccine’s beneﬁts only to society did not increase intentions
(mean intention = 86.4, P = .97).
CONCLUSIONS: We did not see increases in parents’ MMR vaccine
intentions for their infants when societal beneﬁts were emphasized
without mention of beneﬁts directly to the child. This ﬁnding suggests
that providers should emphasize beneﬁts directly to the child. Men-
tioning societal beneﬁts seems to neither add value to, nor interfere
with, information highlighting beneﬁts directly to the child. Pediatrics
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Recentnewsstorieshavecoveredstudies
concerningvaccine-relatedfears,suchas
those surrounding the frequency and
amount of vaccine administration in
childhood1,2 and worries that the child-
hood immunization schedule is linked to
autism.3,4 Other articles have discussed
vaccine-preventable illnesses/death,
such as 105 children dying of inﬂuenza
in the 2012–2013 inﬂuenza season, most
of whom were unvaccinated.5 Yet other
headlines have explicitly mentioned the
importance of societal beneﬁts and
herd immunity6 or articulated the im-
pact of decreased herd immunity when
vaccines are skipped.7–9
Herd immunity, or theprotective beneﬁt
to the overall population as a result of a
sufﬁcient number of individuals in a
given area receiving vaccinations them-
selves, is 1 important beneﬁt of vacci-
nation.10,11 Although childhood vaccine
coverage remains fairly high in the
United States, there has been an overall
decrease in childhood vaccination rates
over the past several years coupled with
increases in rates of nonmedical exemp-
tions for school immunization require-
ments.12,13 There is evidence supporting
geographic clustering of nonmedical
exemptions around the United States12,14
and evidence that these geographic var-
iations in vaccine refusal are linked to
increased risk of illness.15 In recent years,
more parents have refused to vaccinate
their children or requested delayed
vaccine schedules or single-dose ad-
ministration for their children.13 They
have cited fears about overloading their
children’s systems with too many vac-
cines16,17; possible harm to their chil-
dren, for example, due to the chemical
content of vaccines, side effects, or their
children being too young to handle
the vaccines18–22; and concerns about
the link between the measles-mumps-
rubella (MMR) vaccine and autism.17
Vaccine refusals and delays are a threat
to herd immunity,23 and there is evi-
dence to suggest that parents are un-
aware of how immunization results in
protection.16
Research concerning pediatric vaccine
acceptance has evaluated vaccine hesi-
tancy among parents24–27 and strategies
for increasing vaccine acceptance.
One pilot study evaluated the impact of
tailored messages to address speciﬁc
concerns contributing to vaccine hesi-
tancy.28 Public health campaigns have
adopted several communication ap-
proaches, including attempts to assuage
concerns over risks of negative out-
comes after vaccination.29 However, a
recent study in parents of children#17
years suggests that public health messag-
ing concerning MMR vaccination, including
pictorial and narrative communication,
may actually decrease some parents’
intentions to vaccinate their children.30
As a means to increase adults’ vacci-
nation willingness for themselves, re-
search has supported communication
approaches that highlight vaccines’
beneﬁts to society at large (eg, by
presenting arguments that vaccination
promotes herd immunity).31–34 Several
studies have shown that messages
underscoring herd immunity as a vac-
cine beneﬁt lead to increased willing-
ness to vaccinate oneself.31–34 Various
explanations have been presented for
this effect, including leveraging people’s
sense of social responsibility to vaccinate
oneself for the greater good, especially for
the beneﬁt of individuals with compro-
mised immune systems or for whom vac-
cination is not possible.31,32,34 Indeed, the
Centers forDiseaseControl andPrevention
(CDC) uses this type of appeal in its Web
site content: “Unvaccinated people put
themselves and others at risk for measles
and its serious complications.”35 However,
there is a question as to whether such
messaging would be as effective for
parents deciding whether to vaccinate
their children given that some research
indicates surrogate decision-making,
especially for a child, differs from
decision-making for oneself.36,37
A systematic review of the literature on
parents’ decisions surrounding child-
hood vaccination revealed that few
studies have examined whether bene-
ﬁts to others beyond the vaccine re-
cipient inﬂuence parents’ decisions to
vaccinate their children. No single study
has been designed to evaluate this topic
as its primary focus.38 The few studies
that did examine this topic varied in ap-
proach, from focus groups in which the
topic was mentioned spontaneously39
to quantitative assessments such as
surveys.40 Collectively, these studies
produced mixed ﬁndings about the
importance of beneﬁts to others in
parents’ decisions to vaccinate their
children. Some respondents indicated
that beneﬁts to others was a motivator
in their decision to immunize their
children,39,40 and others reported that
it was not a strong factor for them.41
With this in mind, our objective was to
compare messages to determine their
impact on parents’ intention to vacci-
nate their infants for MMR. Speciﬁcally,
we sought to determine whether in-
formation highlighting the MMR vac-
cine’s beneﬁts to the child recipient
and/or to society would increase vac-
cine intentions compared with stan-
dard CDC MMR vaccine information.
METHODS
Overview
This study was a randomized trial in
which we tested variations of vaccine
messages via a national online survey
administered to parents of infants. By
using a factorial design, we examined
4 separate messages: (1) the MMR
Vaccine Information Statement (VIS),
which is standard information from
the CDC42 describing MMR and the
MMR vaccine; (2) VIS plus additional
information highlighting the MMR vac-
cine’s beneﬁts directly to the child
receiving the vaccine; (3) VIS plus ad-
ditional information highlighting the
MMR vaccine’s beneﬁts to society at
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large; and (4) VIS plus additional in-
formation highlighting the MMR vac-
cine’s beneﬁts directly to the child
receiving the vaccine and to society at
large. Our outcome was parents’ in-
tention to vaccinate their infant for
MMR. We hypothesized that the 3 mes-
sage framings emphasizing the MMR
vaccine’s beneﬁts would increase pa-
rental vaccine intention ratings com-
pared with the control message group
who received only the VIS, with the
parents in the fourth group (beneﬁts to
child and society) reporting the high-
est intention ratings.
Study Sample and Recruitment
We conducted an online national survey
in May of 2012. Respondents were re-
cruited by Survey Sampling Inter-
national43 (SSI), a commercial sample
vendor specializing in online survey de-
livery and sample recruitment. They
recruited respondents from their body
of panelists. To be eligible for partic-
ipation in this study, respondents had
to be $18 years of age with an infant
,12 months of age. These eligibility
criteria were established to maximize
the likelihood of recruiting enough re-
spondents who had not yet vaccinated
their infant for MMR. SSI respondents are
compensated by SSI through quarterly
ﬁnancial lotteries of varying amounts of
money for which they receive entries on
the basis of the number of surveys they
complete throughout the year. We con-
ﬁrmed respondents’eligibility via survey
questions. We targeted a sample size of
200 per each of the 4 arms for a total of
∼800. This sample size afforded 80%
power to detect a difference in means
of 5.9 between any 2 arms, assuming
a common SD of 21, using a 2-group
t test with a .05 2-sided signiﬁcance
level.
Study Design
In this block randomized trial, parents
were instructed to respond to the
questions while keeping his or her
infant in mind unless instructed oth-
erwise. There were 4 arms reﬂecting
separate MMR vaccine messaging
approaches to which respondents
were block randomized; for every block
of 4 participants, 1 was randomly as-
signed to each of the 4 possible arms.
This process resulted in a balanced
sample of ∼200 respondents per arm,
for a total of 802 participants.
The control arm received only the CDC’s
VIS concerning MMR and the MMR
vaccine. The MMR VIS describes the
illnesses, including their symptoms, as
well as who should receive the MMR
vaccine, when they should receive it,
contraindications, vaccine risks, and
what to do in the event of a serious
reaction to the vaccine. This information
was followed by a short synopsis of the
VIS written by the investigators. The
remaining 3 arms provided the CDC VIS
and a brief synopsis of the VIS (exactly
as it was provided in the control arm) as
well as additional information either
emphasizing the beneﬁts of the MMR
vaccine to (1) the child receiving the
vaccine, (2) to other members of soci-
ety, or (3) both to the child receiving the
vaccine aswell as to society (see Fig 1 A,
B, and C). The messages were on a time
delay such that they were displayed
without navigation buttons (“Back” and
“Next”) appearing until 15 seconds had
lapsed.
After exposure to 1 of the 4 arms, par-
ticipants were then asked about their
MMR vaccine intentions concerning their
infants. The dependent variable was cap-
turedby the following: “On thescalebelow,
please indicate how likely you are to have
your baby receive the MMR vaccine.” The
11-point response scale ranged from
0 (not at all likely) to 100 (extremely likely)
in increments of 10. Participants also
completed a set of questions to identify
how many children they had and each
child’s gender and age.
In addition, respondents reported pre-
vious vaccine decisions regarding their
infants (eg, history of refusal, delayed or
single-administration requests). If parents
reported multiple children, a general vac-
cine history was also assessed for those
other children. The survey concluded with
a sociodemographic questionnaire.
Pilot testing, conducted online by SSI,
included 25 respondents completing
the survey to ensure that it was un-
derstandable and could be completed
in,20 minutes. After pilot testing, the
surveywas launched online. The Indiana
University Institutional Review Board
approved this study as exempt and
waived informed consent before data
collection.
Statistical Analyses
Weused SAS 9.3 (SAS Institute, Cary, NC)
to analyze data. Descriptive statistics
were calculated including counts and
percentages for categorical variables
and means and SDs for continuous
variables. We used x2 analysis and
1-way analysis of variance (ANOVA), as
appropriate, to determine whether re-
spondent sociodemographic charac-
teristics were equitably distributed
among the messaging arms. We con-
ducted a 1-way ANOVA and an analysis
of covariance to explore the impact
of the 4 types of MMR messages on
parents’ MMR vaccine intentions. Fol-
lowing a signiﬁcant P value for mes-
saging arms, Fisher’s protected least
signiﬁcant difference (LSD) P values
were calculated comparing the mean
vaccine intention ratings between each
of the 3 messaging groups with the
VIS-only control group.
RESULTS
A total of 1314 potential respondents
entered the survey: 321 were de-
termined to be ineligible because they
were not parents of an infant ,12
months of age, 1 respondent had com-
pleted his/her quota for the maximum
number of surveys allowed during the
quarter, and 190 exited the survey before
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being block randomized to a messaging
arm. Thus, 802 respondents (61% of
1314) completed the survey.
Demographic data are presented in
Table 1 arranged by the 4 possible
arms to which participants were ran-
domly assigned. Respondents ranged
in age from 18 to 65 years old (average
age of 29 years). They were mostly
mothers, white, not Hispanic or Latino/a,
well educated, and with a relatively high
household income. Referent infantswere
largely covered by their parents’ in-
surance. Respondents’sociodemographic
characteristics were equitably distrib-
uted among the messaging arms, with
the exception of ethnicity, for which there
was a failure of randomization (P = .04).
Speciﬁcally, only 19 individuals identifying
themselves as Hispanic/Latino were
randomly assigned to the beneﬁts to
society message; this number was
between 34 and 38 for the other
messaging arms.
When asked if they had ever refused
avaccine for their infant, 13%ofparents
responded “yes.” When asked if all of
their children had received all of the
recommended vaccinations and immu-
nizations, 42% reported “yes,” whereas
52% did not have other children. These
characteristics were also equitably
distributed among the 4 arms and are
shown in Table 1 (P . .05).
Overall, respondentsreportedhighMMR
vaccine intentions for their infants
(mean = 88.8, SD = 21). One-way ANOVA
revealed a signiﬁcant main effect of
message framing on the dependent
variable of parents’ MMR vaccine
intentions for their infants (P = .01).
Following this signiﬁcant overall F test
P value, Fisher’s protected LSD P values
showed that, relative to receiving only
the VIS (mean = 86.3, SD = 22.5), ad-
ditional information highlighting the
MMR vaccine’s beneﬁts to the child
produced greater vaccine intentions
FIGURE 1
A, Beneﬁt to infant message. The MMR vaccine protects your child from getting the diseases measles, mumps, or rubella or the complications caused by these
diseases. After receiving this vaccine, yourchildwill notmiss school oractivitiesdue to these illnesses andwill beable toplaywith friendsduringanoutbreak. B,
Beneﬁt to society message. The MMR vaccine prevents your child from spreading measles, mumps, or rubella to those who cannot get the shot. Such people
include infants,1 year old who are too young for the shot, the elderly who have outgrown their immunity, and someone with an immune system that does not
respond to shots, such as some patients with cancer during therapy. C, Beneﬁt to infant and to society message. The MMR vaccine protects your child from
getting the diseases measles, mumps, or rubella or the complications caused by these diseases. After receiving the vaccine, your child will not miss school or
activities due to these illnesses and will be able to play with friends during an outbreak. It also prevents your child from spreading measles, mumps, or
rubella to those who cannot get the shot. Such people include infants,1 year who are too young for the shot, the elderly who have outgrown their immunity,
and someone with an immune system that does not respond to shots, such as some patients with cancer during therapy.
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(mean = 91.6, SD = 16.9; P = .01). Ad-
ditional information highlighting the
MMR vaccine’s beneﬁts to both the
child recipient and to society also
produced greater vaccine intentions
than the VIS (mean = 90.8, SD = 18.2;
P = .03). However, compared with
receiving only the VIS, additional in-
formation highlighting the MMR vac-
cine’s beneﬁts to society did not
produce greater vaccine intentions
(mean = 86.4, SD = 24.9; P = .97) (see
Fig 2).
We also used analysis of covariance
to adjust for ethnicity, because it was
not equitably randomized among the
messaging arms. The main effect of
message framing remained signiﬁcant
(P = .01). We again calculated Fisher’s
LSD P values to compare mean in-
tention ratings between the messaging
groups with the VIS-only control group.
The Fisher’s protected LSD P value be-
tween the VIS only and beneﬁts to child
message remained signiﬁcant (P =
.01), as did the comparison between
the VIS-only and beneﬁts to both child
and society message (P = .04). The
beneﬁts to society message remained
nonsigniﬁcant (P = .95).
DISCUSSION
Our ﬁndings suggest that emphasizing
the variousbeneﬁts ofMMRvaccination
directly to the vaccine recipient or to
societymaydifferentially impact parents’
intentions to vaccinate their infants for
MMR. Speciﬁcally, compared to receiving
only the CDC’s MMR VIS, receiving addi-
tional information underscoring the
MMR vaccine’s beneﬁts directly to the
child recipient or receiving information
underscoring the vaccine’s beneﬁts to
the child and to individuals beyond the
child (ie, society) both resulted in higher
intentions to vaccinate. Information
underscoring the vaccine’s beneﬁts to
society, without explicit mention of
beneﬁts directly to the child, did not
result in higher levels of parental inten-
tions to vaccinate.
This ﬁnding is striking because it does
not replicate patterns observed in re-
search evaluating the impact of in-
formation about herd immunity on
adults’ vaccine intentions for them-
selves.31–34 It appears as though in-
formation linked to increased vaccine
intentions in adults, ie, information
highlighting beneﬁts to others if one
vaccinates him/herself, does not also
produce higher levels of intentions in
parents reporting their intentions to
vaccinate their infants for MMR when
compared with receiving only the MMR
VIS. Although offering additional in-
formation about the MMR vaccine’s
beneﬁts to society does not increase
MMR vaccine intentions of parents for
their infants, it does not reduce vaccine
intentions, nor does it interfere with
additional information highlighting the
MMR vaccine’s beneﬁts directly to the
recipient.
Limitations
There are limitations to our study. Al-
though we recruited a national sample,
it was not a nationally representative
sample. There is the possibility that
respondents who are sociodemo-
graphically different from our sample
could produce different intention re-
sponse patterns as a function of mes-
sage framing. There is evidence to
suggest that there are sociodemo-
graphic differences in vaccine accept-
ability; for example, compared with white
or black parents, Hispanic parents are
less likely to decline vaccination for their
children.44 Additionally, we do not have
data on the 190 individuals who exited the
survey before being assigned to 1 of the
messaging arms; therefore, we are un-
able to conduct analyses to detect any
biases in these individuals who exited the
survey before exposure to messaging.
We also did not assess location of
respondents, and geographic location
has been linked to vaccine-related
decision-making.12,14 We presented
the information to respondents via an
online survey; there is the possibility
that different presentation modalities
could interact with message framing
to produce different vaccine intention
levels. For example, messaging by a
health care provider might be a more
effective approach. Perhaps present-
ing information via personal narra-
tives, as has been done in some vaccine
FIGURE 2
Parents’ MMR vaccine intentions for their infants as a function of message framing. Mean vaccine
intention ratings and 95% conﬁdence intervals are shown.
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research,45,46 in which families share
their thoughts about the importance
of a vaccine’s societal beneﬁts, would
produce different outcomes. The way
we operationalized societal beneﬁts in
our study reﬂects only 1 possible way
that this concept could be deﬁned. We
chose to highlight beneﬁts to others in
one’s community and provide examples
(eg, patients undergoing chemother-
apy) as a means to illustrate the con-
cept of herd immunity, which can be
difﬁcult to explain. Societal beneﬁts of
vaccines could be deﬁned differently,
such as focusing on herd immunity
from a regional or national level.
Moreover, we evaluated vaccine in-
tention as our primary dependent
variable. Although intention is a mod-
erately strong predictor of actual be-
havior,47,48 we cannot conclude from
our data whether parents actually
followed through on their reported
intentions by vaccinating their infants
for MMR. Our respondents reported
high levels of MMR vaccine intention
across all groups (mean = 88.8 on
a 0–100 scale), suggesting a possible
ceiling effect, which may have limited
the impact of our communication ap-
proaches. We did not use vaccine hes-
itancy as a criterion to determine
participant eligibility in this study. Fu-
ture research should focus more spe-
ciﬁcally on vaccine-hesitant parents.26,27
Nonetheless, our study is the ﬁrst,
to our knowledge, to systematically
study this type of message framing on
parents’ intentions to vaccinate their
infants for MMR.
Last, the differences in MMR vaccine
intention levels between messaging
groups were modest. However, we
contend that, despite these relatively
modest differences, they are mean-
ingful. Fromapublichealthperspective,
even small increases in vaccine in-
tention and subsequent behavior can
have signiﬁcant ramiﬁcations for cov-
erage and maintaining herd immunity,
especially in cases of particularly
infectious diseases. Furthermore, we
hypothesize that the mean differences
we observed in our study would be
greater inmagnitude ifavaccine-hesitant
sample were targeted to test the impact
of these messaging approaches.
Conclusions
The implications of this research are
potentially far-reaching. This work con-
tributes to theemerging literatureabout
vaccine communication with parents
and can provide additional evidence
to inform MMR vaccine communication
approaches and perhaps vaccine com-
munication in general. With growing
interest in childhood vaccine decision
aids,49 evidence-based approaches are
critical to ensuring effective communi-
cation about childhood vaccines. More-
over, this work suggests a pattern of
parental focus on the child’s well-being,
perhaps to the exclusion of concerns
about population health.
These data provide additional evidence
suggesting differences in how indi-
viduals respond to information when
making decisions for themselves
compared with how they make deci-
sions for their children. Previous work
has indicated that adults making vac-
cine decisions for themselves can be
motivated by information highlighting
the beneﬁts of vaccination to others
beyond them; however, information
highlighting beneﬁts to others did not
increase parents’ MMR vaccine inten-
tions for their children in our study.
In addition to speciﬁcally studying
the impact of message approaches in
vaccine-hesitant parents, future re-
search should examine these various
communication approaches on actual
vaccine behaviors and more directly
compare parent decision-making for
vaccinating oneself compared with
parent decision-making for vaccinating
a dependent. Future research direc-
tions should also systematically study
the impact of message framing on
parents’ vaccine intentions for their
children for different vaccine types (eg,
determine whether the current pattern
of ﬁndings extends to other childhood
vaccine types, such as inﬂuenza vacci-
nation).
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